問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
廖繼鼎
下載
2024-01-01 - 2027-11-14
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2024-01-01 - 2027-07-31
Participate Sites6Sites
Recruiting6Sites
2023-04-01 - 2026-08-30
Participate Sites7Sites
Recruiting7Sites
2022-05-01 - 2026-12-31
Participate Sites3Sites
Not yet recruiting1Sites
Recruiting2Sites
2020-06-01 - 2027-12-31
2019-04-08 - 2031-12-31
Participate Sites8Sites
Recruiting8Sites
2019-01-01 - 2028-12-31
2024-06-30 - 2029-06-30
2024-04-01 - 2028-01-31
Advanced/Metastatic Solid Tumors
injection
Participate Sites10Sites
Terminated1Sites
2020-01-31 - 2023-10-03
PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
GSK3359609
全部
